Neuronal excitotoxicity produced by high glutamate concentrations in patients with MS could be another mechanism to downregulate BDNF by inhibiting CREB binding to DNA (Zou and Crews, 2006; Kostic et al., 2013). This evidence concerns the gene BDNF and myeloid sarcoma.